Effect of Sufentanil on the Postoperative Pain

ConditionPostoperative Pain, Acute

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age19+

SponsorSeoul National University Hospital

About this trial

This study is a randomized, controlled trial. A total of 48 patients will be randomized to receive sufentanil or remifentanil during robot-assisted nephrectomy surgery.

Eligibility criteria

Qualifiers

Patients who undergo elective robot-assisted nephrectomy surgery

American Society of Anesthesiologists grade 1,2,3

Age > 18 years old

Disqualifiers

Refuse to participate to the study

Allergic history of opioid

chronic pain

opioid user before surgery

Trial design

Treatments tested in this trial

Sufentanil
Remifentanil

Treatment groups

48 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Seoul National University Hospital

Lead sponsor

Source ClinicalTrials.gov